This inventor holds 2 USPTO granted patents. Top assignee: Medstar Health. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations in COVID-19 Treatment by Alexander H. Kroemer
Introduction
Alexander H. Kroemer is an innovative inventor based in Washington, DC. He has made significant contributions to the field of medicine, particularly in the treatment of COVID-19. His work focuses on targeting key inflammatory pathways to combat the effects of the virus.
Latest Patents
Kroemer holds a patent for "Methods for treating COVID-19." This invention relates to methods for treating COVID-19 by targeting the inflammasome/caspase1/pyroptosis axis as a key inflammatory pathway. Specifically, it involves treating a patient infected with SARS-CoV-2 with an effective amount of one or more compounds that directly or indirectly inhibit one or more pathways of the inflammasome/caspase1/pyroptosis axis. He has 1 patent to his name.
Career Highlights
Kroemer is associated with Medstar Health, where he applies his expertise in medical research and innovation. His work has the potential to significantly impact the treatment of COVID-19 and improve patient outcomes.
Collaborations
Some of his notable coworkers include Thomas M. Fishbein and Khalid M. Khan. Their collaboration enhances the research and development efforts in the field of COVID-19 treatment.
Conclusion
Alexander H. Kroemer's innovative approach to treating COVID-19 showcases the importance of targeting inflammatory pathways in medical research. His contributions are vital in the ongoing fight against the pandemic.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile